Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice.

Nitric oxide (NO) is known to be an important endogenous modulator of leukocyte-endothelial cell interactions within the microcirculation. We examined leukocyte rolling and adhesion under baseline conditions and following thrombin (0.25 U/ml) superfusion in the mesentery of wild-type, inducible NOS (iNOS)-deficient (-/-), neuronal NOS (nNOS) -/-, and endothelial cell NOS (ecNOS) -/- mice to further our understanding of NO and leukocyte function. Baseline leukocyte rolling (cells/min) was significantly elevated in both the nNOS -/- (30.0 ± 4.0) and ecNOS -/- mice (67.0 ± 12.0) compared with wild-type mice (11.0 ± 1.4). In addition, baseline leukocyte adherence (cells/100 μm of vessel) was also significantly elevated in the nNOS -/- (5.2 ± 1.0) and ecNOS -/- (13.0 ± 1.3) compared with wild-type animals (1.3 ± 0.5). Deficiency of iNOS had no effect on baseline leukocyte rolling or adhesion in the mesentery. Baseline surface expression of P-selectin was observed in 68.0 ± 9.0% of intestinal venules in ecNOS -/- mice compared with 10.0 ± 2.0% in wild-type mice. Additional studies demonstrated that administration of an anti-P-selectin monoclonal antibody (RB40.34) or the soluble P-selectin ligand, PSGL-1, completely inhibited the increased rolling and firm adhesion response in nNOS -/- and ecNOS -/- mice. Transmigration of neutrophils into the peritoneum following thioglycollate injection was also significantly augmented in nNOS -/- and ecNOS -/- mice. These studies clearly indicate the NO derived from both nNOS and ecNOS is critical in the regulation of leukocyte-endothelial cell interactions.

[1]  P. Kubes,et al.  Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. , 1998, The Journal of clinical investigation.

[2]  J. Mudgett,et al.  Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. , 1998, Circulation.

[3]  R. Virmani,et al.  Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. , 1998, The Journal of clinical investigation.

[4]  P. Huang,et al.  Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. , 1998, The Journal of clinical investigation.

[5]  N. Maeda,et al.  Responses of carotid artery in mice deficient in expression of the gene for endothelial NO synthase. , 1998, American journal of physiology. Heart and circulatory physiology.

[6]  M. Moskowitz,et al.  Neuronal NOS-cGMP-dependent ACh-induced relaxation in pial arterioles of endothelial NOS knockout mice. , 1998, American journal of physiology. Heart and circulatory physiology.

[7]  Fangyi Zhang,et al.  Delayed Reduction of Ischemic Brain Injury and Neurological Deficits in Mice Lacking the Inducible Nitric Oxide Synthase Gene , 1997, The Journal of Neuroscience.

[8]  O. Feron,et al.  Nitric oxide synthases: which, where, how, and why? , 1997, Journal of Clinical Investigation.

[9]  P. Kubes,et al.  Inducible nitric oxide synthase‐deficient mice have enhanced leukocyte–endothelium interactions in endotoxemia , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  M. Seldin,et al.  Clinical and Serologic Manifestations of Autoimmune Disease in MRL-lpr/lpr Mice Lacking Nitric Oxide Synthase Type 2 , 1997, The Journal of experimental medicine.

[11]  P. Huang,et al.  Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. , 1997, Circulation research.

[12]  M. Moskowitz,et al.  [3H]L-NG-Nitroarginine Binding after Transient Focal Ischemia and NMDA-Induced Excitotoxicity in Type I and Type III Nitric Oxide Synthase Null Mice , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  P. Kubes,et al.  Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. , 1997, Gastroenterology.

[14]  A. M. Lefer,et al.  Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. , 1997, The Journal of clinical investigation.

[15]  H. S. Kim,et al.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Moskowitz,et al.  Enlarged Infarcts in Endothelial Nitric Oxide Synthase Knockout Mice are Attenuated by Nitro-L-Arginine , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  P. Libby,et al.  Nitric Oxide Attenuates Vascular Smooth Muscle Cell Activation by Interferon- , 1996, The Journal of Biological Chemistry.

[18]  N. Toda,et al.  Nitroxidergic nerve: regulation of vascular tone and blood flow in the brain. , 1996, Journal of hypertension.

[19]  D. Holtzman,et al.  Neonatal Mice Lacking Neuronal Nitric Oxide Synthase Are Less Vulnerable to Hypoxic–Ischemic Injury , 1996, Neurobiology of Disease.

[20]  O. Smithies,et al.  Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Moskowitz,et al.  Hypertension in mice lacking the gene for endothelial nitric oxide synthase , 1995, Nature.

[22]  J. Loscalzo,et al.  Nitric oxide and its role in the cardiovascular system. , 1995, Progress in cardiovascular diseases.

[23]  P. Libby,et al.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.

[24]  M. Grisham,et al.  Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules. , 1995, The American journal of physiology.

[25]  C. Nathan,et al.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase , 1995, Cell.

[26]  A. M. Lefer,et al.  Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. , 1994, The American journal of physiology.

[27]  A. M. Lefer,et al.  Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. , 1994, Gastroenterology.

[28]  P. Kubes,et al.  Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. , 1994, Circulation research.

[29]  M. Grisham,et al.  Modulation of ischemia/reperfusion-induced microvascular dysfunction by nitric oxide. , 1994, Circulation research.

[30]  S. Snyder,et al.  Targeted disruption of the neuronal nitric oxide synthase gene , 1993, Cell.

[31]  James B. Mitchell,et al.  Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Lefer,et al.  Antineutrophil and Myocardial Protecting Actions of a Novel Nitric Oxide Donor After Acute Myocardial Ischemia and Reperfusion in Dogs , 1993, Circulation.

[33]  P. Kubes,et al.  Nitric oxide prevents leukocyte adherence: role of superoxide. , 1993, The American journal of physiology.

[34]  B. Mayer,et al.  Nitric oxide synthase in cardiac nerve fibers and neurons of rat and guinea pig heart. , 1992, Circulation research.

[35]  A. M. Lefer,et al.  Antishock and endothelial protective actions of a NO donor in mesenteric ischemia and reperfusion. , 1992, Circulatory shock.

[36]  N. Toda,et al.  Regulation by Nitroxidergic Nerve of Arterial Tone , 1992 .

[37]  A. M. Lefer,et al.  The Role of L‐Arginine in Ameliorating Reperfusion Injury After Myocardial Ischemia in the Cat , 1992, Circulation.

[38]  P. Kubes,et al.  Nitric oxide modulates microvascular permeability. , 1992, The American journal of physiology.

[39]  J. Stamler,et al.  The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders. , 1991, Journal of the American College of Cardiology.

[40]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[41]  P. Kubes,et al.  Nitric oxide: an endogenous modulator of leukocyte adhesion. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[42]  J. Schrader,et al.  Control of coronary vascular tone by nitric oxide. , 1990, Circulation research.

[43]  M. Grisham,et al.  Leukocyte adherence to venular endothelium during ischemia-reperfusion. , 1989, The American journal of physiology.

[44]  A. Hassid,et al.  Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.

[45]  S. Moncada,et al.  The anti‐aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide , 1987, British journal of pharmacology.

[46]  Michael J. Davis,et al.  Determination of volumetric flow in capillary tubes using an optical Doppler velocimeter. , 1987, Microvascular research.

[47]  A. Buda,et al.  Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. , 1996, Circulation research.